Skip to content

Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State

Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State: a Randomized, Controlled Cross-over Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06931665
Acronym
EMCS
Enrollment
26
Registered
2025-04-17
Start date
2025-07-08
Completion date
2027-04-30
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimally Conscious State

Brief summary

This study aims to explore the impact of Animal Assisted Therapy (AAT) on brain signal complexity in patients with minimally conscious state (MCS) by analyzing electroencephalogram (EEG) entropy. MCS patients typically exhibit reduced brain entropy compared to healthy individuals, indicating lower brain complexity. The study will assess whether AAT can enhance this complexity, which is crucial for understanding consciousness levels. Entropy, a measure of randomness in brain activity, will be used to evaluate AAT's effectiveness. In addition, electrocardiography (ECG), electrodermal activity (EDA) and behavioral measurements will also be collected.

Interventions

PROCEDUREAnimal Assisted Occupational Therapy

AAT is an ergotherapy including an animal. AAT is a specific type of Animal Assisted Intervention (AAI) with a therapeutic aim.

Sponsors

Rehab Basel
CollaboratorOTHER
University of Basel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized, controlled cross-over within-subject trial with two arms

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inpatients in one of the study sites * Acquired brain injury resulting from either traumatic or non-traumatic events * Diagnosis of MCS defined by CRS-R according to the Aspen criteria (Giacino, 2005) * Informed consent as documented by signature by the patient's legal representative * Physiologically stable * Aged 18 or over

Exclusion criteria

* Phobia or allergies to any of the involved animals * Medical contraindications: acute or chronic disease (e.g. chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes) * Radical changes in medication (decision made with responsible physician)

Design outcomes

Primary

MeasureTime frameDescription
EEG signal complexity 3Before, during and after AAT and TAU. Approximately three weeks.The EEG signal complexity is measured via three measures of entropy computed based on EEG recordings: • Symbolic Transfer Entropy (STE): score usually between 0 and 1 with higher score indicating higher entropy
EEG signal complexity 2Before, during and after AAT and TAU. Approximately three weeks.The EEG signal complexity is measured via entropy computed based on EEG recordings: • Lempel-Ziv complexity (LCZ): score usually between 0 and 1 with higher score indicating higher entropy
EEG signal complexity 1Before, during and after AAT and TAU. Approximately three weeks.The EEG signal complexity is measured via entropy computed based on EEG recordings: • Sample Entropy (SampEn): score usually between 0 and 1 with higher score indicating higher entropy

Secondary

MeasureTime frameDescription
Other physiological measures 3Before, during and after AAT and TAU. Approximately three weeks.• Electrodermal activity (EDA) in uS
Other physiological measures 1Before, during and after AAT and TAU. Approximately three weeks.• Heart rate (HR) in bpm
Other physiological measures 2Before, during and after AAT and TAU. Approximately three weeks.• Heart rate variability (HRV) measured by complexity index (CI): score usually between 0 and 1 with higher score indicating higher complexity

Other

MeasureTime frameDescription
Behavioral data assessing state of consciousness 1From enrollment to the end of treatment at 2 weeks. Day 1 and last day• Coma Recovery Scale - Revised (CRS-R): score from 0 to 23 with higher score indicating higher consciousness level
Behavioral data assessing state of consciousness 2From enrollment to the end of treatment at 2 weeks. Two pre-session measures per week, two post-session measures per week• Basler Vegetative State Assessment (BAVESTA): 22 items with a score from 0 to 5 with higher total score indicating higher level of consciousness

Countries

Switzerland

Contacts

Primary ContactFabio Carbone, MSc
fabio.carbone@unibas.ch+41612076738
Backup ContactKarin Hediger, Prof
karin.hediger@unilu.ch

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026